Literature DB >> 12183691

Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.

Rikiya Ohashi1, Ikumi Tamai, Akihiro Inano, Masaki Katsura, Yoshimichi Sai, Jun-ichi Nezu, Akira Tsuji.   

Abstract

The organic cation/carnitine transporter OCTN2 mediates transport of carnitine and organic cations in Na(+)-dependent and Na(+)-independent manners, respectively. However, the mechanism of molecular recognition of different substrates has not been clarified yet. We previously found a single amino acid change in OCTN2, Ser467Cys (S467C), in the Japanese population and observed a decreased carnitine transport but unchanged organic cation transport compared with wild type. Therefore, we conducted detailed kinetic and functional analyses of the substrate recognition sites of wild-type and S467C-mutant OCTN2. The K(m) value for carnitine of S467C-mutant was increased about 15-fold over that of the wild type. Mutual inhibition kinetics of carnitine and tetraethylammonium (TEA) were not completely competitive, suggesting that the binding sites are very close to each other, but not identical. Several organic anions such as valproate, as well as organic cations, significantly inhibited carnitine and TEA uptake by OCTN2, and valproate showed Na(+)-dependent inhibition of OCTN2-mediated TEA uptake. The Na(+)-activation kinetics of the S467C mutant was similar to that of the wild type. Furthermore, a significant decrease of the TEA uptake-inhibitory potency of valproate was observed in S467C-mutant OCTN2. These observations suggest that the decrease in affinity of S467C-mutant OCTN2 for carnitine was caused by functional alteration of the anion (carboxyl moiety of carnitine) recognition site located in trans-membrane domain 11, which is closely related to the Na(+)-binding site, on OCTN2 protein. These results demonstrate that OCTN2 has functional sites for carnitine and Na(+) and that the carnitine-binding site is involved, in part, in the recognition of organic cations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183691     DOI: 10.1124/jpet.102.036004

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin.

Authors:  Hugues Chanteux; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.

Authors:  Cristina Amat di San Filippo; Orly Ardon; Nicola Longo
Journal:  Biochim Biophys Acta       Date:  2010-11-29

3.  Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening.

Authors:  Moeno Kadoguchi; Hiroshi Arakawa; Ryokichi Honda; Kazuki Hotta; Yoshiyuki Shirasaka; Yoshiharu Deguchi; Ikumi Tamai
Journal:  Pharm Res       Date:  2022-03-21       Impact factor: 4.200

Review 4.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 5.  The SLC22 drug transporter family.

Authors:  Hermann Koepsell; Hitoshi Endou
Journal:  Pflugers Arch       Date:  2003-07-19       Impact factor: 3.657

6.  Multiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sites.

Authors:  Sebastiano Bellanca; Robert L Summers; Max Meyrath; Anurag Dave; Megan N Nash; Martin Dittmer; Cecilia P Sanchez; Wilfred D Stein; Rowena E Martin; Michael Lanzer
Journal:  J Biol Chem       Date:  2014-11-06       Impact factor: 5.157

7.  Whole grain intake associated molecule 5-aminovaleric acid betaine decreases β-oxidation of fatty acids in mouse cardiomyocytes.

Authors:  Olli Kärkkäinen; Tomi Tuomainen; Ville Koistinen; Marjo Tuomainen; Jukka Leppänen; Tuomo Laitinen; Marko Lehtonen; Jaana Rysä; Seppo Auriola; Antti Poso; Pasi Tavi; Kati Hanhineva
Journal:  Sci Rep       Date:  2018-08-29       Impact factor: 4.379

Review 8.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.